Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001387131-18-004026)

Filing Details

Accession Number:
0001387131-18-004026
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-14 21:20:11
Reporting Period:
2018-08-10
Accepted Time:
2018-08-14 21:20:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1528557 Corindus Vascular Robotics Inc. CVRS Surgical & Medical Instruments & Apparatus (3841) 300687898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1700257 A Louis Cannon 309 Waverley Oaks Road, Suite 105
Waltham MA 02452		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-10 20,500 $0.96 168,408 No 4 P Direct
Common Stock Acquisiton 2018-08-13 10,500 $0.95 178,909 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,557,436 Indirect See Footnote
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9527 to $0.9771, inclusive. The reporting person undertakes to provide to Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Includes 53,326 shares of common stock related to restricted stock units ("RSUs") granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date.
  3. 87,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
  4. 98,301 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
  5. Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.